Cargando…
The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death worldwide and new approaches for both diagnosis and treatment are required. Autoantibodies directed against apolipoprotein A-I (ApoA-I) represent promising biomarkers for use in risk stratification of CVD and may also play a dire...
Autores principales: | Pagano, Sabrina, Gaertner, Hubert, Cerini, Fabrice, Mannic, Tiphaine, Satta, Nathalie, Teixeira, Priscila Camillo, Cutler, Paul, Mach, François, Vuilleumier, Nicolas, Hartley, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503694/ https://www.ncbi.nlm.nih.gov/pubmed/26177543 http://dx.doi.org/10.1371/journal.pone.0132780 |
Ejemplares similares
-
Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases
por: Teixeira, Priscila Camillo, et al.
Publicado: (2014) -
Autoantibodies to Apolipoprotein A-1 in Cardiovascular Diseases: Current Perspectives
por: Teixeira, P. C., et al.
Publicado: (2012) -
Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population
por: Vuilleumier, Nicolas, et al.
Publicado: (2020) -
Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms
por: Antiochos, Panagiotis, et al.
Publicado: (2017) -
Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
por: Bridge, Simon H., et al.
Publicado: (2018)